Related Experiment Video
Updated: Apr 4, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Republished: Left atrial appendage occlusion
1The Division of Cardiovascular Diseases and Department of Internal Medicine, University of Alabama, Birmingham, Alabama, USA The Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.
Insights
Left atrial appendage (LAA) occlusion effectively prevents stroke in atrial fibrillation (AF) patients. Further data is needed for widespread adoption of this LAA closure strategy.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Atrial fibrillation (AF) poses a high risk of stroke due to thrombus formation in the left atrial appendage (LAA).
- Preventing thromboembolic events is crucial in managing AF patients.
Purpose of the Study:
- To review the current status of LAA occlusion for stroke prevention in AF.
- To analyze clinical data, techniques, devices, and future directions for LAA occlusion.
Main Methods:
- Review of current clinical data on LAA occlusion.
- Analysis of available LAA occlusion devices and techniques.
- Discussion of challenges and future prospects in LAA occlusion.
Main Results:
- LAA occlusion is a safe and effective alternative for stroke prevention in selected AF patients.
- Challenges to adoption include limited randomized trial data, cost-effectiveness, and procedural risks.
Conclusions:
- LAA occlusion is a promising strategy for AF-related stroke prevention.
- Further research is needed to address data gaps and facilitate broader clinical adoption.
Abstract:
Left atrial appendage (LAA) occlusion for stroke and thromboembolism prevention in patients with atrial fibrillation (AF) represents a significant advancement in the field of cardiovascular disease. Prevention and avoidance of the devastating consequences of thromboembolic complications from AF continues to be central in the management of these patients. The role of LAA as a nidus for thrombus formation is well documented. Multiple approaches to exclude the LAA from the circulation either percutaneously or surgically have been described and are undergoing testing. Although pharmacological therapy for stroke prevention remains the cornerstone of treatment, device and surgical exclusion of the LAA have proven to be viable alternatives in carefully selected patients. Even though current evidence show that LAA occlusion is safe and effective, approval and adoption of this strategy has been quite difficult due to paucity of randomised clinical trial data on the risk and benefit ratio, cost effectiveness and the issues of procedural risk as well as longer-term outcome. This review aims to provide an update on the current status of LAA occlusion, specifically looking at interpretation of current clinical data, available techniques and devices, issues with current devices and future direction.
